These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21489417)

  • 41. Using World Health Organization Disability Assessment Schedule 2.0 in people with schizophrenia: a 4-year follow-up.
    Chen R; Liou TH; Miao NF; Chang KH; Yen CF; Liao HF; Chi WC; Chou KR
    Eur Arch Psychiatry Clin Neurosci; 2020 Apr; 270(3):301-310. PubMed ID: 31011812
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Validation of the Spanish Personal and Social Performance scale (PSP) in outpatients with stable and unstable schizophrenia.
    Garcia-Portilla MP; Saiz PA; Bousoño M; Bascaran MT; Guzmán-Quilo C; Bobes J;
    Rev Psiquiatr Salud Ment; 2011 Jan; 4(1):9-18. PubMed ID: 23446097
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Disability in depression and back pain: evaluation of the World Health Organization Disability Assessment Schedule (WHO DAS II) in a primary care setting.
    Chwastiak LA; Von Korff M
    J Clin Epidemiol; 2003 Jun; 56(6):507-14. PubMed ID: 12873644
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparing Global Assessment of Functioning (GAF) and World Health Organization Disability Assessment Schedule (WHODAS) 2.0 in schizophrenia.
    Gspandl S; Peirson RP; Nahhas RW; Skale TG; Lehrer DS
    Psychiatry Res; 2018 Jan; 259():251-253. PubMed ID: 29091824
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patient-reported impact of symptoms in schizophrenia scale (PRISS): Development and validation.
    Moreno-Küstner B; Fábrega-Ruz J; Gonzalez-Caballero JL; Reyes-Martin S; Ochoa S; Romero-Lopez-Alberca C; Cid J; Vila-Badia R; Frigola-Capell E; Salvador-Carulla L
    Acta Psychiatr Scand; 2022 Jun; 145(6):640-655. PubMed ID: 35188673
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Psychological evaluations of operation of patients with mental disorders].
    Gomez P; Enders JE; Alvarado R; Cometto MC; Fernández AR
    Rev Fac Cien Med Univ Nac Cordoba; 2015; 72(4):243-9. PubMed ID: 27107275
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The 12-item World Health Organization Disability Assessment Schedule II (WHO-DAS II): a nonparametric item response analysis.
    Luciano JV; Ayuso-Mateos JL; Aguado J; Fernandez A; Serrano-Blanco A; Roca M; Haro JM
    BMC Med Res Methodol; 2010 May; 10():45. PubMed ID: 20487526
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The predictive validity of a diagnosis of schizophrenia. A report from the International Study of Schizophrenia (ISoS) coordinated by the World Health Organization and the Department of Psychiatry, University of Nottingham.
    Mason P; Harrison G; Croudace T; Glazebrook C; Medley I
    Br J Psychiatry; 1997 Apr; 170():321-7. PubMed ID: 9246249
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The use of the French Dimensional Apathy Scale (f-DAS) to assess apathy in schizophrenia: Properties and profiles.
    Barek LM; Mercy G; Gautier C; Noquet M; Legros-Lafarge E; Fiegl L; Fiard D; Allain P
    J Affect Disord; 2021 Nov; 294():181-188. PubMed ID: 34298224
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Utility of the twelve-item World Health Organization Disability Assessment Schedule II (WHO-DAS II) for discriminating depression "caseness" and severity in Spanish primary care patients.
    Luciano JV; Ayuso-Mateos JL; Fernandez A; Aguado J; Serrano-Blanco A; Roca M; Haro JM
    Qual Life Res; 2010 Feb; 19(1):97-101. PubMed ID: 20016936
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Validity and Reliability of the Premorbid Adjustment Scale in a Sample of Turkish Schizophrenic Patients.
    Altunsoy N; Kocabaş T; Bayad S; Elbir M; Aydemir Ö
    Alpha Psychiatry; 2024 Jan; 25(1):15-22. PubMed ID: 38799496
    [TBL] [Abstract][Full Text] [Related]  

  • 52. World health organization disability assessment schedule 2.0 as an objective assessment tool for predicting return to work after a stroke.
    Huang SW; Chi WC; Chang KH; Yen CF; Liao HF; Escorpizo R; Liou TH
    Disabil Rehabil; 2018 Oct; 40(21):2592-2597. PubMed ID: 28657351
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Course and predictors of disability in Thai patients with schizophrenia: A 2-year, multi-center, prospective, observational study.
    Srisurapanont M; Kunchanaphongphan T; Chokemaitree N; Prachason T; Kanchanatawan B; Suttajit S; Sanguanvichaikul T; Trisukon W; Dendumrongkul P; Chinvararak C; Kawilapat S
    Asian J Psychiatr; 2022 Apr; 70():103044. PubMed ID: 35219052
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Reliability and validity of the brief dimensional apathy scale.
    Radakovic R; Gray D; Dudley K; Mioshi E; Dick D; Melchiorre G; Gordon H; Newton J; Colville S; Pal S; Chandran S; Abrahams S
    Arch Clin Neuropsychol; 2020 Jul; 35(5):539-544. PubMed ID: 32045001
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Initiating care for untreated schizophrenia patients and results of one year follow-up.
    Srinivasan TN; Rajkumar S; Padmavathi R
    Int J Soc Psychiatry; 2001; 47(2):73-80. PubMed ID: 11434413
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modification and validation of a performance-based functional capacity instrument for individuals with schizophrenia.
    Zhou Q; Chan RCK; Yu X; Zheng M; Shum DHK; Shi C
    Psychiatry Res; 2019 Nov; 281():112572. PubMed ID: 31627071
    [TBL] [Abstract][Full Text] [Related]  

  • 57. WHODAS 2.0: Associations of functional disability with sex, age, and length of care in outpatients with schizophrenia-spectrum disorders.
    Thai H; Robertson C; Friberg L; Hatko A; Ielo D; Attwood DG
    Psychiatry Res; 2022 Jul; 313():114583. PubMed ID: 35533470
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gender differences on functioning in depressive patients.
    Gili M; Castro A; Navarro C; Molina R; Magallón R; García-Toro M; Roca M
    J Affect Disord; 2014 Sep; 166():292-6. PubMed ID: 25012444
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differences in levels of disability and quality of life between genders in schizophrenia remission.
    Kujur NS; Kumar R; Verma AN
    Ind Psychiatry J; 2010 Jan; 19(1):50-4. PubMed ID: 21694792
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An evaluation of functional mental capacity in forensic mental health practice: the Dundrum capacity ladders validation study.
    Moynihan G; O'Reilly K; O'Connor J; Kennedy HG
    BMC Psychiatry; 2018 Mar; 18(1):78. PubMed ID: 29580216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.